Cellulose nanocrystal cationic derivative induces NLRP3 inflammasome-dependent IL-1β secretion associated with mitochondrial ROS production

Biochemistry and Biophysics Reports

Volumn 4, Issue , 2015, Pages 1-9

  Sunasee, Rajesh ^a   Araoye, Erinolaoluwa ^a   Pyram, Dejhy ^a   Hemraz, Usha D ^b   Boluk, Yaman ^b   Ckless, Karina ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

Cationic needle like nanomaterial; Cellulose nanocrystals; IL 1 ; Mitochondrial ROS; Mouse macrophages; NLRP3 inflammasome

Indexed keywords

EID: 84940652151     PISSN: None     EISSN: 24055808     Source Type: Journal    
DOI: 10.1016/j.bbrep.2015.08.008     Document Type: Article

References (36)

1. Kalia Susheel, Dufresne Alain, Cherian Bibin Mathew, Kaith B.S., Avérous Luc, Njuguna James, Nassiopoulos E. Nassiopoulos, cellulose-based bio- and nanocomposites: a review. Int. J. Polym. Sci. 2011, 2011:35.
2. Jackson J.K., Letchford K., Wasserman B.Z., Ye L., Hamad W.Y., Burt H.M. The use of nanocrystalline cellulose for the binding and controlled release of drugs. Int. J. Nanomed. 2011, 6:321-330.
3. Habibi Y., Lucia L.A., Rojas O.J. Cellulose nanocrystals: chemistry, self-assembly, and applications. Chem. Rev. 2010, 110:3479-3500.
4. Klemm D., Kramer F., Moritz S., Lindstrom T., Ankerfors M., Gray D., Dorris A. Nanocelluloses: a new family of nature-based materials. Angew. Chem. 2011, 50:5438-5466.
5. Moon R.J., Martini A., Nairn J., Simonsen J., Youngblood J. Cellulose nanomaterials review: structure, properties and nanocomposites. Chem. Soc. Rev. 2011, 40:3941-3994.
6. Peng B.L., Dhar N., Liu H.L., Tam K.C. Chemistry and applications of nanocrystalline cellulose and its derivatives: A nanotechnology perspective. Can. J. Chem. Eng. 2011, 89:15.
7. Dong S., Roman M. Fluorescently labeled cellulose nanocrystals for bioimaging applications. J. Am. Chem. Soc. 2007, 129:13810-13811.
8. Mahmoud K.A., Mena J.A., Male K.B., Hrapovic S., Kamen A., Luong J.H. Effect of surface charge on the cellular uptake and cytotoxicity of fluorescent labeled cellulose nanocrystals. ACS Appl. Mater. Interfaces 2010, 2:2924-2932.
9. Kovacs T., Naish V., O'Connor B., Blaise C., Gagne F., Hall L., Trudeau V., Martel P. An ecotoxicological characterization of nanocrystalline cellulose (NCC). Nanotoxicology 2010, 4:255-270.
10. Lam E., Male K.B., Chong J.H., Leung A.C., Luong J.H. Applications of functionalized and nanoparticle-modified nanocrystalline cellulose. Trends Biotechnol. 2012, 30:283-290.
11. Yanamala N., Farcas M.T., Hatfield M.K., Kisin E.R., Kagan V.E., Geraci C.L., Shvedova A.A. In vivo evaluation of the pulmonary toxicity of cellulose nanocrystals: a renewable and sustainable nanomaterial of the future. ACS Sustain. Chem. Eng. 2014, 2:1691-1698.
12. Palomaki J., Valimaki E., Sund J., Vippola M., Clausen P.A., Jensen K.A., Savolainen K., Matikainen S., Alenius H. Long, needle-like carbon nanotubes and asbestos activate the NLRP3 inflammasome through a similar mechanism. ACS Nano 2011, 5:6861-6870.
13. Dostert C., Petrilli V., Van Bruggen R., Steele C., Mossman B.T., Tschopp J. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008, 320:674-677.
14. Yazdi A.S., Guarda G., Riteau N., Drexler S.K., Tardivel A., Couillin I., Tschopp J. Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1{alpha} and IL-1{beta}. Proc. Natl. Acad. Sci. USA 2010, 104:19449-19454.
15. Dinarello C.A. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 2009, 27:519-550.
16. Martinon F., Mayor A., Tschopp J. The inflammasomes: guardians of the body. Annu. Rev. Immunol. 2009, 27:229-265.
17. Piccini A., Carta S., Tassi S., Lasiglie D., Fossati G., Rubartelli A. ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1beta and IL-18 secretion in an autocrine way. Proc. Natl. Acad. Sci. USA 2008, 105:8067-8072.
18. Cruz C.M., Rinna A., Forman H.J., Ventura A.L., Persechini P.M., Ojcius D.M. ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages. J. Biol. Chem. 2007, 282:2871-2879.
19. Martinon F. Signaling by ROS drives inflammasome activation. Eur. J. Immunol. 2010, 40:616-619.
20. Jabaut J., Ather J.L., Taracanova A., Poynter M.E., Ckless K. Mitochondria-targeted drugs enhance Nlrp3 inflammasome-dependent IL-1beta secretion in association with alterations in cellular redox and energy status. Free Radic. Biol. Med. 2013, 60:233-245.
21. Shimada K., Crother T.R., Karlin J., Dagvadorj J., Chiba N., Chen S., Ramanujan V.K., Wolf A.J., Vergnes L., Ojcius D.M., Rentsendorj A., Vargas M., Guerrero C., Wang Y., Fitzgerald K.A., Underhill D.M., Town T., Arditi M. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 2012, 36:401-414.
22. Boluk Y., Lahiji R., Zhao L., McDermott M.T. Suspension viscosities and shape parameter of cellulose nanocrystals (CNC). Colloids Surf. 2011, 377:297-303.
23. Hemraz U.D., Campbell K.A., Burdick J.S., Ckless K., Boluk Y., Sunasee R. Cationic poly(2-aminoethylmethacrylate) and poly(N-(2-aminoethylmethacrylamide) modified cellulose nanocrystals: synthesis, characterization, and cytotoxicity. Biomacromolecules 2015, 16:319-325.
24. Ather J.L., Ckless K., Martin R., Foley K.L., Suratt B.T., Boyson J.E., Fitzgerald K.A., Flavell R.A., Eisenbarth S.C., Poynter M.E. Serum amyloid a activates the NLRP3 Inflammasome and promotes Th17 allergic asthma in mice. J. Immunol. 2011, 187:64-73.
25. Myhre O., Andersen J.M., Aarnes H., Fonnum F. Evaluation of the probes 2',7'-dichlorofluorescin diacetate, luminol, and lucigenin as indicators of reactive species formation. Biochem. Pharmacol. 2003, 65:1575-1582.
26. Gross O., Thomas C.J., Guarda G., Tschopp J. The inflammasome: an integrated view. Immunol. Rev. 2011, 243:136-151.
27. Bilski P., Belanger A.G., Chignell C.F. Photosensitized oxidation of 2',7'-dichlorofluorescin: singlet oxygen does not contribute to the formation of fluorescent oxidation product 2',7'-dichlorofluorescein. Free Radic. Biol. Med. 2002, 33:938-946.
28. Bonini M.G., Rota C., Tomasi A., Mason R.P. The oxidation of 2',7'-dichlorofluorescin to reactive oxygen species: a self-fulfilling prophesy?. Free Radic. Biol. Med. 2006, 40:968-975.
29. Tassi S., Carta S., Delfino L., Caorsi R., Martini A., Gattorno M., Rubartelli A. Altered redox state of monocytes from cryopyrin-associated periodic syndromes causes accelerated IL-1beta secretion. Proc. Natl. Acad. Sci. USA 2010, 107:9789-9794.
30. Bulua A.C., Simon A., Maddipati R., Pelletier M., Park H., Kim K.Y., Sack M.N., Kastner D.L., Siegel R.M. Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAP). J. Exp. Med. 2011, 208:519-533.
31. Tschopp J. Mitochondria: sovereign of inflammation?. Eur. J. Immunol. 2011, 41:1196-1202.
32. Zhou R., Yazdi A.S., Menu P., Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011, 469:221-225.
33. Lunov O., Syrovets T., Loos C., Nienhaus G.U., Mailander V., Landfester K., Rouis M., Simmet T. Amino-functionalized polystyrene nanoparticles activate the NLRP3 inflammasome in human macrophages. ACS Nano 2011, 5:9648-9657.
34. Henao-Mejia J., Elinav E., Strowig T., Flavell R.A. Inflammasomes: far beyond inflammation. Nat. Immunol. 2012, 13:321-324.
35. Cui H., Wu W., Okuhira K., Miyazawa K., Hattori T., Sai K., Naito M., Suzuki K., Nishimura T., Sakamoto Y., Ogata A., Maeno T., Inomata A., Nakae D., Hirose A., Nishimaki-Mogami T. High-temperature calcined fullerene nanowhiskers as well as long needle-like multi-wall carbon nanotubes have abilities to induce NLRP3-mediated IL-1beta secretion. Biochem. Biophys. Res. Commun. 2014, 452:593-599.
36. Lonez C., Bessodes M., Scherman D., Vandenbranden M., Escriou V., Ruysschaert J.M. Cationic lipid nanocarriers activate toll-like receptor 2 and NLRP3 inflammasome pathways. Nanomed. Nanotechnol. Biol. Med. 2014, 10:775-782.